These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 620717)

  • 1. Activation of the carcinogen N-hydroxy-2-acetylaminofluorene by rat mammary peroxidase.
    Reigh DL; Stuart M; Floyd RA
    Experientia; 1978 Jan; 34(1):107-8. PubMed ID: 620717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid hydroperoxide activation of N-hydroxy-N-acetylaminofluorene via a free radical route.
    Floyd RA; Soong LM; Walker RN; Stuart M
    Cancer Res; 1976 Aug; 36(8):2761-7. PubMed ID: 1277186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obligatory free radical intermediate in the oxidative activation of the carcinogen N-hydroxy-2-acetylaminofluorene.
    Floyd RA; Soong LM
    Biochim Biophys Acta; 1977 Jun; 498(1):244-9. PubMed ID: 884152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Horseradish peroxidase/hydrogen peroxide-catalyzed oxidation of the carcinogen N-hydroxy-N-acetyl-2-aminofluorene as effected by cyanide and ascorbate.
    Floyd RA; Soong LM; Culver PL
    Cancer Res; 1976 Apr; 36(4):1510-9. PubMed ID: 1260768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free radical activation of N-hydroxy-2-acetylaminofluorene by methemoglobin and hydrogen peroxide.
    Walker RN; Floyd RA
    Cancer Biochem Biophys; 1979; 4(2):87-93. PubMed ID: 552909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spin trapping of the primary radical involved in the activation of the carcinogen N-hydroxy-2-acetylaminofluorene by cumene hydroperoxide-hematin.
    Rosen GM; Rauckman EJ
    Mol Pharmacol; 1980 Mar; 17(2):233-8. PubMed ID: 6248759
    [No Abstract]   [Full Text] [Related]  

  • 7. Peroxidative metabolism of a carcinogen, N-hydroxy-N-2-fluorenylacetamide, by rat uterus and mammary gland in vitro.
    Malejka-Giganti D; Ritter CL; Decker RW; Suilman JM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6200-6. PubMed ID: 3779640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of reducing agents on N-acetoxy- and N-hydroxy-2-acetylaminofluorene-induced mutagenesis.
    Rosin MP; Stich HF
    Cancer Res; 1978 May; 38(5):1307-10. PubMed ID: 346207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the metabolic activation of the carcinogen N-hydroxy-N-2-acetylaminofluorene. 3. Oxidation with horseradish peroxidase to yield 2-nitrosofluorene and N-acetoxy-N-2-acetylaminofluorene.
    Bartsch H; Hecker E
    Biochim Biophys Acta; 1971 Jun; 237(3):567-78. PubMed ID: 4330271
    [No Abstract]   [Full Text] [Related]  

  • 10. Free radicals in arylamine carcinogenesis.
    Floyd RA
    Natl Cancer Inst Monogr; 1981 Dec; (58):123-31. PubMed ID: 6281648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel oxidation of the carcinogen N-hydroxy-N-2-fluorenylacetamide catalyzed by peroxidase/H2O2/Br-.
    Ritter CL; Malejka-Giganti D
    Biochem Biophys Res Commun; 1985 Aug; 131(1):174-81. PubMed ID: 4038295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deacetylation of N-hydroxy-2-acetylaminofluorene by rat liver microsomes and carboxyl esterase.
    Steward JE; Floyd RA
    Cancer Biochem Biophys; 1980; 5(1):47-53. PubMed ID: 6260332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-hydroxy-2-fluorenylacetamide, an active intermediate of the mammary carcinogen N-hydroxy-2-fluorenylbenzenesulfonamide.
    Malejka-Giganti D; Gutmann HR
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):92-7. PubMed ID: 1187717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and persistence of DNA adducts from the carcinogen N-hydroxy-2-acetylaminofluorene in rat mammary gland in vivo.
    Allaben WT; Weis CC; Fullerton NF; Beland FA
    Carcinogenesis; 1983 Aug; 4(8):1067-70. PubMed ID: 6872152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irradiation-induced adduct formation of RNA with carcinogenic arylamine derivatives.
    Cardona RA; King CM; Redpath JL
    Cancer Res; 1975 Aug; 35(8):2007-14. PubMed ID: 1149020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation.
    Allaben WT; Weeks CE; Weis CC; Burger GT; King CM
    Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the synthetic ultimate carcinogens, N-sulfonoxy- and N-acetoxy-2-acetylaminofluorene, and of enzymatically activated N-hydroxy-2-acetylaminofluorene with nucleophiles.
    Smith BA; Springfield JR; Gutmann HR
    Carcinogenesis; 1986 Mar; 7(3):405-11. PubMed ID: 3512117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of arylhydroxamic acids by N-O-acyltransferase of rat mammary gland.
    King CM; Traub NR; Lortz ZM; Thissen MR
    Cancer Res; 1979 Sep; 39(9):3369-72. PubMed ID: 476668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAT LIVER AFTER N-HYDROXY-2-ACETYLAMINOFLUORENE. ULTRASTRUCTURE.
    HARTMANN HA
    Arch Pathol; 1965 Feb; 79():126-34. PubMed ID: 14232928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.